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The distribution of glycogen synthase (casein) kinase-1 (CK-1) among different rat tissues and subcellular 
fractions was investigated. Using casein, glycogen synthase and phosphorylase kinase as substrates, CK-I 
activity was detected in kidney, spleen, liver, testis, lung, brain, heart, skeletal muscle and adipose tissue. 
The distribution of (X-1 among different subcellular fractions of rat liver was; cytosol(72. lx), microsome 
(17.6x), mitoczhondria (9.6%) and nuclei (0.7%). CK-1 from rat tissues was shown to have a similarly wide 
substrate specifldity as highly putilied CK-1 from rabbit skeletal muscle. Such wide substrate specificity and 
distribution among different mammalian tissues and subcellular organelles indicate that CK-1 may be in- 
volved in the regulation of diverse cellular functions. 
Phosphorylation Casein kinase Multzjiinctional enzyme Widespread distribution 
1. INTRODUCTION 2. EXPERIMENTAL 
Glycogen synthase (casein) kinase-1 &K-l) is a 
cyclic nucleotide- and calcium-independent protein 
kinase first identified in rabbit skeletal muscle [I] 
and later in rat and rabbit liver [2,3]. Skeletal mus- 
cle CK-1 was initially identified as a glycogen syn- 
thase kinase that could also phosphorylate casein 
and phosvitin. However, we have since shown that 
CK-1 has a very wide substrate specificity and may 
therefore be involved in the regulation of diverse 
cellular functions [4]. 
In this study we provide further evidence that 
agrees with the above hypothesis. We found that 
CK-I is widely distributed among different rat 
tissues and among the different subcellular frac- 
tions of a particular tissue. 
Abbreviations: TPCK. L-1-tosylamido-2-phenylethyl 
chloromethyl ketone; TLCK, AJ-rr-p-tosyl-L-lysine 
chloromethyl ketone; PMSF, phenylmethylsulfonyl 
fluoride 
2.1. Materials 
Tubulin [5] and microtubule-associated protein-2 
[6] were purified from rat brain. Myosin light 
chain [7] was purified from turkey gizzard and was 
a mixture of the 20 and 17 kDa light chains. 
Glycogen synthase 181 and phosphorylase kinase 
191 were purified from rabbit skeletal muscle. 
[y-32P]ATP was from New England Nuclear. 
Tissues from Sprague-Dawley rats (150-200 g) 
were rapidly removed after killing, frozen in liquid 
nitrogen and stored at -70°C. ’ 
2.2. Tissue distribution of CK-I 
Frozen rat tissues (12-15 g) were thawed, cut in- 
to small pieces and homogenized for 30 s, twice in 
3 vols of Buffer A [50 mM Tris-HCI (pH 7.5) con- 
taining 1 mM dithiothreitol, 1 mM EDTA, 0.25 M 
sucrose, 0.5 mM PMSF, 0.05 mM TPCK, 0.05 
mM TLCK, and 1 mg/I each of pepstatin A, 
leupeptin and chymostatin]. The homogenate was 
centrifuged at 10000 xg for 15 min, then at 
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100 000 x g for 1 h. The supernatant was applied to 
a phosphocellulose column (1.5 x 7 cm) equili- 
brated with Buffer A + 0.1 M KCl. The column 
was washed with 25 ml Buffer A + 0.10 M KC1 
followed by 50 ml Buffer A + 0.35 M KCI. CK-1 
and CK-2 were eluted consecutively from the col- 
umn with 25 ml Buffer A + 0.60 M KC1 and 25 ml 
Buffer A + 1.0 M KCl, respectively. The eluted 
enzymes were diluted with Buffer A to reduce KC1 
concentration to 0.3 M and concentrated to 1 ml 
by ultrafiltration. 
2.3. Subcellular localization of CK-I in rat liver 
Cytoplasmic, mitochondrial and microsomal 
fractions were prepared as described [lo]. The liver 
(15 g) from a freshly killed rat was homogenized 
(12 strokes) in 3 vols of Buffer A utilizing a Potter- 
Elvehjem homogenizer with a loose fitting Teflon 
pestle. The homogenate was filtered through 4 
layers of cheese cloth and centrifuged at 600 x g for 
10 min. The pellet was discarded and the superna- 
tant was centrifuged at 115OOxg for 10 min. The 
pellet containing mitochondria was washed twice 
with Buffer A and resuspended in the same buffer. 
The postmitochondrial supernatant was centri- 
fuged at 100000 x g for 60 min. The microsomal 
pellet was washed twice with Buffer A and re- 
suspended in the same buffer. The supernatant 
from the initial centrifugation at 100 000 x g was 
used as the cytosol fraction. 
Nuclei were separately prepared from a fresh 
liver (15 g) as described [l 11. Briefly, the liver was 
rinsed in Buffer B [50 mM Tris-HCl (pH 7.5) con- 
taining 25 mM KCl, 5 mM MgC12, and 1 mM 
PMSF] containing 0.25 M sucrose. The liver was 
then homogenized in 2 vols of Buffer B containing 
0.25 M sucrose as described above. To each 3 ml 
portion of homogenate was added 6 ml of Buffer 
B containing 2.3 M sucrose. After mixing, the 
solution was underlaid with 3 ml of Buffer B con- 
taining 2.3 M sucrose. The solutions were then cen- 
trifuged at 124000xg for 30 min at 3°C in a SW 
41 rotor. The supernatant was discarded and the 
pellets containing nuclei were resuspended in Buf- 
fer A. 
CK-1 and CK-2 were solubilized from mitochon- 
drial, microsomal and nuclear fractions by the ad- 
dition of sodium deoxycholate and KC1 to final 
concentrations of 0.3% and 1.0 M, respectively. 
After sonification (3 times, each for 10 s with an 
interval of 10 s) at maximum power of a Kontes 
Sonifier the fractions were gently stirred at 4°C for 
30 min. They were then centrifuged at 100 000 x g 
for 1 h. The supernatant was used to purify CK-1 
and CK-2 on a phosphocellulose column as out- 
lined above. 
2.4. Enzyme assays 
CK-1 and CK-2 were assayed at 30°C in a reac- 
tion mixture (0.05 ml) containing 4 mg/ml casein, 
25 mM Tris-HCl buffer (pH 7.4), 1 mM dithio- 
threitol, 0.5 mM EGTA, 5 mM KF, 10 mM mag- 
nesium acetate, 0.10 mM [T-~~P]ATP. The reac- 
tions were initiated by the addition of [Y-~~P]ATP 
and aliquots were removed at different times for 
the determination of “P incorporation into pro- 
tein [12]. One unit of Ck-1 or CK-2 is defined as 
the amount of enzyme catalyzing the incorporation 
of 1 pmol 32P from [Y-~~P]ATP into casein (4 
mg/ml) per min at 30°C. Lactate dehydrogenase 
[ 131, glutamate dehydrogenase [ 141 and glucose-6- 
phosphatase [15] were assayed as described. 
Fmtio,, tiumber 
Fig.1. Fractionation of rat liver cytosol by 
phosphocellulose chromatography. The soluble fraction 
(100000 Xg supernatant) from rat liver (34 g) was 
prepared and applied to a phosphocellulose column 
(2 x 11 cm) equilibrated with Buffer A. The column was 
washed with Buffer A + 0.10 M KC1 followed by Buffer 
A + 0.35 M KCI. The column was finally eluted with a 
linear gradient of KC1 (0.35 + 1.2 M). Fractions of 6 ml 
were collected. Aliquots (0.005 ml) were used for 
measuring casein kinase activity (0). (A) Absorbance at 
280 nm; (- ) KC1 concentrations. 
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3. RESULTS 
3.1. Separation of CK-I and CK-2 by 
phosphocellulose chromatography 
When the soluble fraction from rat liver is frac- 
tionated on a phosphocellulose column two casein 
kinase activity peaks can clearly be resolved (fig. I), 
as also shown by others [2]. These kinase eluted at 
approx. 0.5 and 0.7 M KC1 and have been termed 
casein kinase-1 (CK-1) and casein kinase-2 (CK-2), 
respectively. Our previous studies have shown that 
CK-1 can phosphorylate many other substrates in 
addition to casein [4]. From fig.1 it can also be 
seen that CK-1 represents only about one-third of 
the total casein kinase activity. Further, we have 
determined that cyclic AMP-dependent protein 
kinase, calcium- and phospholipid-dependent pro- 
tein kinase [ 161, and kinase FA [ 171 either do not 
bind to the phosphocellulose column or are eluted 
at lower KC1 concentrations than do CK-1 and 
CK-2 (not shown). This observation is important 
because our results, especially on the substrate 
specificity of CK-1 (see fig.2), cannot be explained 
as being due to the action of these enzymes. 
3.2. Wide distribution of CK-I among different 
rat tissues 
We have surveyed for the presence of CK-1 (and 
CK-2) in the soluble fraction of different rat tissues 
using the protocol outlined in fig. 1, CK-1 was first 
eluted from the column with 0.6 M KCl; by in- 
creasing KC1 to 1 .O M CK-2 was eluted. In this way 
CK-1 and Ck-2 from 9 rat tissues were quantitated 
(table 1). It can be seen that these enzymes are pre- 
sent in all tissues surveyed, with the highest ac- 
tivities of CK-1 occurring in kidney, spleen, and 
liver. Similar to the results observed for liver 
(fig.1) the activity of CK-2 was much higher than 
CK-1 in all tissues. 
3.3. Phosphorylation of multiple substrates 
by CK-1 
We have highly purified CK-1 from rabbit 
skeletal muscle [l] and shown that this enzyme can 
phosphorylate several other substrates besides ca- 
sein [4]. However, casein kinases similar to CK-1 
and apparently having a more restricted substrate 
specificity have been described by others [18]. It 
was therefore essential to demonstrate that CK-1 
purified from the different rat tissues (table 1) does 
Fig.2. Phosphorylation of multiple substrates by rat 
kidney CK-1. The different substrates (each at 0.5 
mg/ml, except glycogen synthase which was at 0.25 
mg/ml) were phosphorylated by rat kidney CK-1 (12 ,ug) 
in a reaction mixture (0.05 ml) similar to that described 
in section 2. Aliquots (0.01 ml) were removed at the dif- 
ferent times for the determination of 32P incorporation 
into protein. Rat kidney CK-1 was partially purified on 
a phosphocellulose column as outlined in fig. 1. (M) 
Casein, (D-O) tubulin, (A----A) glycogen synthase 
WI, (a--a) microtubule-associated protein-2 
[MAP-21, (M) phosphorylase kinase [Ph.K.], 
(O-II) smooth muscle myosin light chain [Sm.MLC]. 
Table 1 
Activities of CK-1 and CK-2 purified from the soluble 
fraction of different rat tissues 
Tissue Kinase activity 
(units/g tissue) 
Percent 
CK-1 CK-2 Total CK-1 
Kidney 400 460 860 41 
Spleen 345 114 1119 31 
Liver 232 474 706 33 
Testis 157 717 874 18 
Lung 133 354 487 21 
Brain 125 291 416 30 
Heart 116 416 532 22 
Skeletal muscle 27 34 61 44 
Adipose tissue 4 10 14 29 
CK-1 and CK-2 were purified from the soluble fraction 
of the different tissues as outlined in section 2. The ac- 
tivities of CK-1 and CK-2 were assayed using casein as 
a substrate. Since CK-2 uses GTP as a substrate and is 
inhibited by heparin [ 181, assays for CK-1 contained 0.2 
mM GTP and 2 pg/ml heparin to inhibit any con- 
taminating CK-2 
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Table 2 
Subcellular distribution of rat liver CK-1 and CK-2 
Cell fraction Protein Casein kinases Marker enzymes 
(mg/g liver) 
Activity Specific activity Distribution LDH GDH G-6-Pase 
(units/g liver) (units/mg protein) (percent) (umol/min (nmol/min per 
per m8 mg protein) 
CK-1 CK-2 CK-1 CK-2 CK-1 CK-2 
protein) 
Nuclei 0.5 2.2 20.9 4.4 41.8 0.7 3.9 1.6 8.2 1.8 
Mitochondria 15.3 30.7 10.9 2.0 0.7 9.6 2.1 1.0 69.9 34.6 
Microsomes 15.4 56.4 25.6 3.7 1.7 17.6 4.8 0.7 1.3 283.8 
Cytosol 62.9 231.7 473.7 3.7 7.5 72.1 89.2 21.4 5.7 3.9 
CK-1 and CK-2 were solubilized from the particulate fractions by treating with 1.0 KC1 and 0.3% sodium deoxycholate for 
30 min at 4°C. Solubilized CK-1 and CK-2 were then separated on a phosphocellulose column. The activities of these nzymes 
were assayed using casein as a substrate. The activities of the marker enzymes were assayed after solubilization of the par- 
ticulate fractions. LDH, lactate dehydrogenase; GDH, glutamate dehydrogenase; G-6-Pase, glucose-6-phosphatase 
have a substrate specificity as wide as the rabbit 
skeletal muscle enzyme. As shown in fig.2, rat 
kidney Ck-1 can phosphorylate tubulin, glycogen 
synthase, microtubule-associated protein-2, phos- 
phorylase kinase, smooth muscle myosin light 
chain and casein. Troponin is also a substrate for 
the kinase (not shown). All these proteins were 
previously shown to be substrates for rabbit 
skeletal muscle CK-1 [4,19]. We did not repeat the 
experiment shown in fig.2 using CK-1 from each of 
the different tissues listed in table 1. However, we 
did find that CK-1 from all 9 tissues can phos- 
phorylate phosphorylase kinase and glycogen syn- 
thase under conditions identical to those outlined 
for fig.2 (not shown). These results, therefore, sug- 
gest that CK-1 purified from the different rat 
tissues in this study is the same as the rabbit 
skeletal muscle enzyme [4]. 
3.4. Subcellular distribution of CK-I 
In keeping with the postulated multiple roles for 
CK-1 [4] we investigated whether this enzyme is 
present in different cellular compartments. Since 
we already know that the activity of CK-1 (and 
Ck-2) is very high in the cytosol (table 1) it is essen- 
tial to document whether these enzymes are also 
present in the particulate fractions. ’ Rat liver 
homogenate was therefore resolved into different 
subfractions from which CK-1 and CK-2 were 
solubilized and separated by phosphocellulose col- 
umn chromatography. Both CK-1 and CK-2 are 
present in all 4 subfractions (table 2). However, the 
distribution of these two enzymes among the 
various subcellular fractions is different. CK-1 is 
the predominant form in mitochondria and micro- 
somes, whereas CK-2 is greater than CK-1 in nuclei 
and cytosol. Further, both CK-1 and CK-2 are 
largely soluble enzymes (72 and 89% of the total 
recovered activities, respectively). However, CK-1 
activity is significant especially in microsomes 
(18%) and mitochondria (10%). We found that 
partially purified CK-1 from rat liver microsomes 
can also phosphorylate the same substrates as does 
cytosolic CK-1 (fig.2 and data not shown). These 
results indicate that besides being widely distributed 
among different tissues, CK-1 is also present in all 
cell compartments, thus implying its importance in 
the regulation of different cellular functions. 
4. DISCUSSION 
Previous studies have shown that many tissues 
contain at least two major classes of casein kinases, 
similar to CK-1 and CK-2 (see fig.1). CK-2 is an 
oligomeric protein (Mr 135 000) containing two 
types of subunits termed a (Z% 42000) and p (Mr 
27000). In addition, the enzyme is inhibited by 
heparin and can use both ATP and GTP as phos- 
phoryl donors. Using these criteria CK-2 purified 
from different sources by several laboratories 
seems to represent the same enzyme [18]. CK-1 
from the different sources, by contrast, is more 
difficult to compare. The enzyme is apparently 
monomeric and has an M, of 30000-40000. It is 
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not inhibited by heparin and does not use GTP as 
a substrate [181. Because of the unavailability of an 
inhibitor or activator specific for CK-1, it is dif- 
ficult to classify CK-1 purified by different labora- 
tories as being the same or different kinases. One 
way by which such classification can be made is to 
examine the specificity of CK-1 purified from dif- 
ferent sources for defined protein substrates. We 
have compared the specificity of CK-1 from dif- 
ferent rat and rabbit tissues for a variety of protein 
substrates. 
Previously, we have shown that CK-1 highly puri- 
fied from rabbit skeletal muscle could phosphoryl- 
ate many different substrates: casein, glycogen 
synthase, phosphorylase kinase, troponin, myosin 
light chain and light chain kinase from both 
smooth and skeletal muscle, tubulin and micro- 
tubule-associated protein-2 [4,19]. Here we have 
used casein, glycogen synthase and phosphorylase 
kinase as substrates to identify CK-1 from 9 dif- 
ferent rat tissues. Further detailed analysis showed 
that CK-1 from rat kidney can phosphorylate the 
same proteins that are substrates for CK-1 from 
rabbit skeletal muscle (fig.2). We have taken this 
analysis one step further and shown that CK-1 
purified from rabbit skeletal muscle (and liver) and 
rat liver can phosphorylate the same sites on 
glycogen synthase and smooth myosin light chain 
(not shown). These results, therefore, suggest hat 
the CK-1 that we studied from rabbit skeletal mus- 
cle and liver and the different rat tissues represents 
a single kinase having a wide substrate specificity. 
Many of the substrates phosphorylated by CK-1 
are also subtrates for cyclic AMP-dependent pro- 
tein kinase 14,191. The wide substrate specificity of 
the latter kinase, its ubiquitous distribution among 
mammalian tissues, and its importance is regu- 
lating multiple cellular processes is well established 
[20,21]. Similarly, we propose that the wide sub- 
strate specificity of CK-I and its ubiquitous distri- 
bution among mammalian tissues and cell organ- 
elles indicate that it is also involved in the regula- 
tion of diverse cellular functions. The mode by 
which CK-1 may regulate different cell functions is 
still obscure. However, we have recently shown 
that the activity of CK-1 may be regulated through 
the action of glucagon in isolated hepatocytes [22]. 
Further studies are clearly required to evaluate the 
importance of CK-1 in regulating different cellular 
processes. 
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